Market Overview:
The global tamoxifen market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. Tamoxifen is a drug used for the treatment of breast cancer and ovarian cancer. It belongs to the class of drugs known as selective estrogen receptor modulators (SERMs). The growth in this market can be attributed to factors such as rising incidence of breast and ovarian cancers, increasing awareness about tamoxifen, and growing demand for targeted therapies. However, patent expirations of key products in this market are likely to restrain its growth over the forecast period. The global tamoxifen market can be segmented on the basis of type into tables and capsules. On the basis of application, it can be divided into breast cancer, ovarian cancer, and other applications. Geographically, it can be segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
A medication used to treat breast cancer. Tamoxifen is a type of hormone therapy that works by blocking the effects of estrogen in the body.
Tables:
Tables is a database management system that provides organization, integrity, and security to data. It offers features such as record locking, multiversion concurrency control, transaction logging etc. tables helps in storing information in the form of records that can be retrieved later on when needed.
Capsules:
Capsules are small containers made up of gelatin, which is an animal by-product. It is used to contain drugs and help it in protecting the drug molecules for a longer period of time. Capsules also provide the required amount of moisture so that the drugs can be easily administered with ease. The major function performed by capsules includes protection from stomach acids and enzymes as well as providing delayed-release mechanism to allow extended action over a specific period of time.
Application Insights:
Breast cancer accounted for the largest revenue share of over 40% in 2017. Breast cancer is one of the most common types of cancers diagnosed among women aged 50 years and above. According to data published by WHO, it has been estimated that around 1 in 8 breast carcinoma cases occur globally. The high prevalence coupled with rising awareness about early detection is expected to fuel market growth during the forecast period.
Ovarian cancer accounted for a significant revenue share owing to increasing incidence rates and awareness regarding early detection among women aged 35 years and above.
Regional Analysis:
North America was the largest revenue-generating region in 2017. The regional market is expected to grow at a CAGR of XX% during the forecast period. This growth can be attributed to various factors such as high awareness about tamoxifen and its benefits, presence of key manufacturers, and increasing incidence rates of breast cancer & ovarian cancer in U.S., which has led to an increase in demand for anti-cancer drugs like tamoxifen citrate tablets.
Asia Pacific is estimated to be one of the fastest growing regions during the same period owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure & economic development in emerging countries like China.
Growth Factors:
- Increasing incidence of breast cancer: The incidence of breast cancer is increasing at a rapid pace across the globe. This is expected to drive the demand for tamoxifen in the coming years.
- Growing awareness about early detection and treatment options: There is a growing awareness among women about the importance of early detection and treatment options for breast cancer. This is likely to boost demand for tamoxifen in the near future.
- Rising popularity of targeted therapies: The popularity of targeted therapies is rising rapidly, especially among patients with advanced-stage cancers. This is likely to create significant opportunities for tamoxifen in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tamoxifen Market Research Report
By Type
Tables, Capsules
By Application
Breast Cancer, Ovarian Cancer, Other
By Companies
AstraZeneca, Sanofi, Pfizer, Mylan , Wockhardt, Cipla, Actiza Pharmaceutical, Teva, Shanghai Forward Technology, Bayer, Liaoning Kangtai Pharmaceutical, Fu 'an Pharmaceutical Group, Yangtze River Pharmaceutical Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Tamoxifen Market Report Segments:
The global Tamoxifen market is segmented on the basis of:
Types
Tables, Capsules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer, Ovarian Cancer, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Sanofi
- Pfizer
- MylanÂ
- Wockhardt
- Cipla
- Actiza Pharmaceutical
- Teva
- Shanghai Forward Technology
- Bayer
- Liaoning Kangtai Pharmaceutical
- Fu 'an Pharmaceutical Group
- Yangtze River Pharmaceutical Group
Highlights of The Tamoxifen Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tables
- Capsules
- By Application:
- Breast Cancer
- Ovarian Cancer
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tamoxifen Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tamoxifen is a medication used to treat breast cancer. It works by blocking the estrogen receptors in the body, which can help to reduce the growth of cancer cells. Tamoxifen may also help to prevent other types of cancers from developing in the future.
Some of the major companies in the tamoxifen market are AstraZeneca, Sanofi, Pfizer, Mylan‚Â , Wockhardt, Cipla, Actiza Pharmaceutical, Teva, Shanghai Forward Technology, Bayer, Liaoning Kangtai Pharmaceutical, Fu 'an Pharmaceutical Group, Yangtze River Pharmaceutical Group.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Tamoxifen Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Tamoxifen Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Tamoxifen Market - Supply Chain
4.5. Global Tamoxifen Market Forecast
4.5.1. Tamoxifen Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Tamoxifen Market Size (000 Units) and Y-o-Y Growth
4.5.3. Tamoxifen Market Absolute $ Opportunity
5. Global Tamoxifen Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Tamoxifen Market Size and Volume Forecast by Type
5.3.1. Tables
5.3.2. Capsules
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Tamoxifen Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Tamoxifen Market Size and Volume Forecast by Application
6.3.1. Breast Cancer
6.3.2. Ovarian Cancer
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Tamoxifen Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Tamoxifen Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Tamoxifen Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Tamoxifen Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Tamoxifen Demand Share Forecast, 2019-2029
9. North America Tamoxifen Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Tamoxifen Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Tamoxifen Market Size and Volume Forecast by Application
9.4.1. Breast Cancer
9.4.2. Ovarian Cancer
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Tamoxifen Market Size and Volume Forecast by Type
9.7.1. Tables
9.7.2. Capsules
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Tamoxifen Demand Share Forecast, 2019-2029
10. Latin America Tamoxifen Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Tamoxifen Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Tamoxifen Market Size and Volume Forecast by Application
10.4.1. Breast Cancer
10.4.2. Ovarian Cancer
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Tamoxifen Market Size and Volume Forecast by Type
10.7.1. Tables
10.7.2. Capsules
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Tamoxifen Demand Share Forecast, 2019-2029
11. Europe Tamoxifen Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Tamoxifen Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Tamoxifen Market Size and Volume Forecast by Application
11.4.1. Breast Cancer
11.4.2. Ovarian Cancer
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Tamoxifen Market Size and Volume Forecast by Type
11.7.1. Tables
11.7.2. Capsules
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Tamoxifen Demand Share, 2019-2029
12. Asia Pacific Tamoxifen Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Tamoxifen Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Tamoxifen Market Size and Volume Forecast by Application
12.4.1. Breast Cancer
12.4.2. Ovarian Cancer
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Tamoxifen Market Size and Volume Forecast by Type
12.7.1. Tables
12.7.2. Capsules
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Tamoxifen Demand Share, 2019-2029
13. Middle East & Africa Tamoxifen Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Application
13.4.1. Breast Cancer
13.4.2. Ovarian Cancer
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Tamoxifen Market Size and Volume Forecast by Type
13.7.1. Tables
13.7.2. Capsules
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Tamoxifen Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Tamoxifen Market: Market Share Analysis
14.2. Tamoxifen Distributors and Customers
14.3. Tamoxifen Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AstraZeneca
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Mylan
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wockhardt
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cipla
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Actiza Pharmaceutical
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teva
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shanghai Forward Technology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bayer
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Liaoning Kangtai Pharmaceutical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Fu 'an Pharmaceutical Group
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Yangtze River Pharmaceutical Group
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
